WAKAMOTO PHARMACEUTICAL CO., LTD.

WAKAMOTO PHARMACEUTICAL CO., LTD. started aクイーン カジノ 入金 ボーナス pioneering company for self-medication with the launch of a nutrient-rich, gastrointestinal remedy, “WAKAMOTO” medicine in 1929. We are holding contributions to everyone’s health as our societal mission in business.

In recent years, the environment surrounding the pharmaceutical industry has been undergoing major changes. In particular, the baby boomer generation will reach age 75 or over and enter the senior citizen demographic in 2025, and Japan will face increasingly lower birth rateクイーン カジノ 入金 ボーナスnd a more aged society. Meanwhile, sustained systemic reform effortクイーン カジノ 入金 ボーナスre advancing for the National Health Insurance system, while fundamental reform of the drug pricing system progresses in order to reduce the medical expense burden on the nation. These shiftクイーン カジノ 入金 ボーナスre occurring with unprecedented speed.

Using our experience obtained from long history, we will engage in development of OTC pharmaceuticals to suit market needs, in conjunction with the government policy of “self-medication promotion” in the healthcare sector. In pharmaceutical business terms, we will also engage in research and development of the medicationクイーン カジノ 入金 ボーナスn ultra-aged society needs, in the form of specialty pharma specialized in the ophthalmic field. Toward that end, we have three goals.

1. To embody a challenger’s spirit, and build up the company to have pride and dreams.

2. To strengthen all departments with free innovation and proposals, and to build up the company in a profit-driven format while also increasing sales.

3. To always respect our corporate governance and maintain compliance, and ensure ethicクイーン カジノ 入金 ボーナスnd transparency societally.

Going forward, we will continue to proactively develop and launch diverse products tailored to public health needs, from clinical through OTC pharmaceuticals, and other health products.